Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Respira Therapeutics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10470
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary arterial hypertension and other diseases. Respira also delivers drug, carrier blended, and particle engineered formulations over various drug powder payloads. The company offers pure drug, carrier blended, and particle engineered formulations for a range of drug powder payloads. Respira is headquartered in Albuquerque, New Mexico, the US.

Respira Therapeutics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Respira Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Respira Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Respira Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Respira Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Respira Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Respira Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Respira Therapeutics to Raise Funds through Series B Preferred Stock Financing 10
Respira Therapeutics Secures USD0.6 Million in Venture Funding 11
Respira Therapeutics Secures USD1.5 Million in Venture Funding 12
Respira Therapeutics Raises Funds Through Venture Financing 13
Respira Therapeutics To Raise Up To US$3 Million In Series B Financing 14
Respira Therapeutics Plans To Raise US$15 Million In Series C Financing 15
Partnerships 16
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 16
Respira Therapeutics Inc – Key Competitors 17
Respira Therapeutics Inc – Key Employees 18
Respira Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Respira Therapeutics Inc, Medical Equipment, Key Facts 2
Respira Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Respira Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Respira Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Respira Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Respira Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Respira Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Respira Therapeutics to Raise Funds through Series B Preferred Stock Financing 10
Respira Therapeutics Secures USD0.6 Million in Venture Funding 11
Respira Therapeutics Secures USD1.5 Million in Venture Funding 12
Respira Therapeutics Raises Funds Through Venture Financing 13
Respira Therapeutics To Raise Up To US$3 Million In Series B Financing 14
Respira Therapeutics Plans To Raise US$15 Million In Series C Financing 15
United Therapeutics Enters into Licensing Agreement with Respira Therapeutics 16
Respira Therapeutics Inc, Key Competitors 17
Respira Therapeutics Inc, Key Employees 18

List of Figures
Respira Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Respira Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Respira Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Respira Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Respira Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Respira Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Respira Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Respira Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hallador Energy Co (HNRG):企業の財務・戦略的SWOT分析
    Hallador Energy Co (HNRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sunquest Information Systems, Inc.-医療機器分野:企業M&A・提携分析
    Summary Sunquest Information Systems, Inc. (Sunquest), a subsidiary of Roper Industries, is a healthcare information technology (IT) company that provides diagnostic informatics solutions to laboratories and healthcare organizations worldwide. The company offers laboratory information system that au …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • ResApp Health Ltd (RAP):製薬・医療:M&Aディール及び事業提携情報
    Summary ResApp Health Ltd (ResApp) formerly, Narhex Life Sciences Limited is a digital health company that develops smartphone applications for the diagnosis and management of respiratory disease. It's digital healthcare solutions assist doctors and patients to diagnose and manage respiratory diseas …
  • Indianapolis Power & Light Co:企業の戦略的SWOT分析
    Indianapolis Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Calavo Growers, Inc. (CVGW):企業の財務・戦略的SWOT分析
    Calavo Growers, Inc. (CVGW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Techtronic Industries Co Ltd (669)
    Techtronic Industries Co Ltd (669) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務情報
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lear Corp (LEA):企業の財務・戦略的SWOT分析
    Lear Corp (LEA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • OMRON Corporation:企業の戦略・SWOT・財務分析
    OMRON Corporation - Strategy, SWOT and Corporate Finance Report Summary OMRON Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chromatin Inc:企業のM&A・事業提携・投資動向
    Chromatin Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chromatin Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の財務・戦略的SWOT分析
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. EyePoint dura …
  • Intermountain Healthcare Inc-医療機器分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Auspex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Auspex Pharmaceuticals Inc (Auspex), a subsidiary of Teva Pharmaceutical Industries Ltd is a biopharmaceutical company that develops and commercializes novel medicines for the treatment of movement disorders and other rare diseases including orphan diseases. The company offers products for t …
  • Ostfold Energi AS:企業の戦略的SWOT分析
    Ostfold Energi AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Agilent Technologies, Inc.:企業の戦略・SWOT・財務情報
    Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Equinor ASA (EQNR):電力:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • RKW SE:企業の戦略的SWOT分析
    RKW SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • W. L. Gore & Associates, Inc.:企業の戦略・SWOT・財務情報
    W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report Summary W. L. Gore & Associates, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆